Patents by Inventor Yohan HAZOT

Yohan HAZOT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS AND USES THEREOF
    Publication number: 20230346805
    Abstract: The present disclosure relates to compositions, including foamable compositions with improved properties, such as those comprising waxes, emollients, foam adjuvants and/or active agents, and methods for preparing and using them.
    Type: Application
    Filed: July 30, 2020
    Publication date: November 2, 2023
    Inventors: Iain Stuart, Flor De Maria Alvarez Mitre, Russell Elliott, Gary Lawrence, Meital Cohen-Asis, Anat London-Drori, Yohan Hazot, Ariel Margulis
  • TOFACITINIB-CONTAINING ANHYDROUS ELASTOMER-BASED GEL FORMULATIONS
    Publication number: 20230320984
    Abstract: The present disclosure relates to novel topical formulations containing a tofacitinib and or a fingolimod that are useful for treating dermatological conditions, such as atopic dermatitis, psoriasis, vitiligo and eczema.
    Type: Application
    Filed: January 13, 2023
    Publication date: October 12, 2023
    Inventors: Iain Stuart, Russell Elliott, Yohan Hazot, Gareth Winckle, Ariel Margulis
  • STABLE TOPICAL TETRACYCLINE COMPOSITIONS
    Publication number: 20230123488
    Abstract: Provided herein are compositions and methods for treating skin disorders, e.g., acne and/or rosacea. In some embodiments, the compositions may comprise carriers which are suitable for stabilizing an unstable active agent, e.g., a tetracycline antibiotic.
    Type: Application
    Filed: June 19, 2018
    Publication date: April 20, 2023
    Inventors: Yohan HAZOT, Tal BERMAN, Jana ZAILER, Orit AMSALEM, David SCHUZ, Anat LONDON-DRORI
  • TOPICAL COMPOSITION COMPRISING TOFACITINIB AND FINGOLIMOD
    Publication number: 20230037905
    Abstract: The present disclosure relates to novel topical formulations containing a tofacitinib and or a fingolimod that are useful for treating dermatological conditions, such as atopic dermatitis, psoriasis, and eczema.
    Type: Application
    Filed: December 31, 2020
    Publication date: February 9, 2023
    Inventors: Russell ELLIOTT, Yohan HAZOT, Gareth WINCKLE, Ariel MARGULIS
  • Compositions and methods for treating rosacea and acne
    Patent number: 11324691
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Grant
    Filed: October 20, 2020
    Date of Patent: May 10, 2022
    Assignee: Journey Medical Corporation
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • Foamable compositions, breakable foams and their uses
    Patent number: 11219631
    Abstract: A substantially surface active agent-free foamable composition which includes short-chain alcohol, water, polymer, fatty alcohol or fatty acid or a combination of fatty alcohol and fatty acid and propellant. A substantially surface active agent-free foamable composition which includes, water, polymer, fatty alcohol or fatty acid and propellant. A method of treatment using a substantially surface active agent-free foamable compositions.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: January 11, 2022
    Assignee: Vyne Pharmaceuticals Inc.
    Inventors: Dov Tamarkin, Enbal Ziv, Yohan Hazot, David Schuz
  • COMPOSITIONS AND METHODS FOR TREATING ROSACEA AND ACNE
    Publication number: 20210205212
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Application
    Filed: October 20, 2020
    Publication date: July 8, 2021
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • Surfactant-free, water-free formable composition and breakable foams and their uses
    Patent number: 10967063
    Abstract: A substantially surface active agent-free and foam adjuvant-free composition which includes a hydrophobic solvent, a wax and a propellant. A substantially surface active agent-free and foam adjuvant-free composition, further comprising, a tetracycline antibiotic, or one or more other active agents. A method of treatment, using a substantially surface active agent-free and substantially foam adjuvant-free composition.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: April 6, 2021
    Assignee: Vyne Therapeutics Inc.
    Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
  • Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
    Patent number: 10946101
    Abstract: A substantially surface active agent free composition which includes a hydrophobic solvent, and/or a petrolatum, a paraffin wax and/or a fatty alcohol, a fatty acid and/or a wax and/or shea butter, with and without a propellant. A substantially surface active agent free composition, further comprising, a tetracycline antibiotic, or a vitamin D derivative, or one or more other active agents. A method of treatment using a substantially surface active agent free composition.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: March 16, 2021
    Assignee: Vyne Therapeutics Inc.
    Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
  • COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF
    Publication number: 20210069335
    Abstract: The present disclosure relates generally to compositions for cosmetic or pharmaceutical application. The compositions include a carrier and rheology modulators.
    Type: Application
    Filed: October 1, 2020
    Publication date: March 11, 2021
    Inventors: Dov Tamarkin, Elana Gazal, Yohan Hazot, David Schuz, Irakliy Papiashvili
  • SURFACTANT-FREE, WATER-FREE FOAMABLE COMPOSITION AND BREAKABLE FOAMS AND THEIR USES
    Publication number: 20210023226
    Abstract: A substantially surface active agent-free and foam adjuvant-free composition which includes a hydrophobic solvent, a wax and a propellant. A substantially surface active agent-free and foam adjuvant-free composition, further comprising, a tetracycline antibiotic, or one or more other active agents. A method of treatment, using a substantially surface active agent-free and substantially foam adjuvant-free composition.
    Type: Application
    Filed: October 9, 2020
    Publication date: January 28, 2021
    Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
  • COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF
    Publication number: 20210015928
    Abstract: The present disclosure relates generally to compositions for cosmetic or pharmaceutical application. The compositions include a carrier and rheology modulators.
    Type: Application
    Filed: September 29, 2020
    Publication date: January 21, 2021
    Inventors: Dov Tamarkin, Elana Gazal, Yohan Hazot, David Schuz, Irakliy Papiashvili
  • SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES
    Publication number: 20210015927
    Abstract: A substantially surface active agent free composition which includes a hydrophobic solvent, and/or a petrolatum, a paraffin wax and/or a fatty alcohol, a fatty acid and/or a wax and/or shea butter, with and without a propellant. A substantially surface active agent free composition, further comprising, a tetracycline antibiotic, or a vitamin D derivative, or one or more other active agents. A method of treatment using a substantially surface active agent free composition.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 21, 2021
    Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
  • TETRACYCLINE MANAGEMENT OF EGFR INHIBITOR ASSOCIATED DERMATOSES
    Publication number: 20210000842
    Abstract: Methods of treatment and dosage regimes using a composition comprising a tetracycline antibiotic in treating or alleviating a disorder including EGFRI associated rash, EGFRI associated rash related symptoms, a tetracycline antibiotic responsive EGFRI associated rash related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, P. EGFRI associated rash bacteria associated disorders and other superficial infections, including skin infections are provided.
    Type: Application
    Filed: September 15, 2020
    Publication date: January 7, 2021
    Inventors: Meir EINI, Mitchell SHIRVAN, Rita KEYNAN, Tal BERMAN, David SCHUZ, Yohan HAZOT
  • Compositions and methods for treating rosacea and acne
    Patent number: 10849847
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: December 1, 2020
    Assignee: Foamix Pharamaceuticals Ltd.
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • Compositions, gels and foams with rheology modulators and uses thereof
    Patent number: 10835613
    Abstract: The present disclosure relates generally to compositions for cosmetic or pharmaceutical application. The compositions include a carrier and rheology modulators.
    Type: Grant
    Filed: April 17, 2019
    Date of Patent: November 17, 2020
    Assignee: Foamix Pharmaceuticals Ltd.
    Inventors: Dov Tamarkin, Elana Gazal, Yohan Hazot, David Schuz, Irakliy Papiashvili
  • Compositions, gels and foams with rheology modulators and uses thereof
    Patent number: 10821187
    Abstract: The present disclosure relates generally to compositions for cosmetic or pharmaceutical application. The compositions include a carrier and rheology modulators.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: November 3, 2020
    Assignee: Foamix Pharmaceuticals Ltd.
    Inventors: Dov Tamarkin, Elana Gazal, Yohan Hazot, David Schuz, Irakliy Papiashvili
  • TOPICAL TETRACYCLINE COMPOSITIONS
    Publication number: 20200261586
    Abstract: A topical therapeutic hydrophobic breakable composition includes a carrier comprising (a) about 60% to about 99% by weight of at least one hydrophobic oil; (b) at least one viscosity-modifying agents selected from the group consisting of a fatty alcohol, a fatty acid and a wax; and (c) a tetracycline antibiotic, characterized in that at least part of the tetracycline antibiotic is suspended in the composition; the viscosity of the composition is at least about 30% higher than the viscosity of the carrier without the tetracycline antibiotic; and is higher than the viscosity of the hydrophobic oil and the tetracycline antibiotic without the viscosity modifying agents. The tetracycline is chemically stable in the composition for at least six months; wherein more than about 90% of the tetracycline has not broken down. The composition is packaged as a breakable foam that breaks easily upon application of shear force.
    Type: Application
    Filed: February 28, 2020
    Publication date: August 20, 2020
    Applicant: Foamix Pharmaceuticals Ltd.
    Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
  • FOAMABLE VEHICLES AND PHARMACEUTICAL COMPOSITIONS COMPRISING APROTIC POLAR SOLVENTS AND USES THEREOF
    Publication number: 20200222320
    Abstract: The present invention teaches a foamable pharmaceutical and cosmetic compositions comprising an aprotic polar solvent; foam compositions and uses thereof.
    Type: Application
    Filed: February 3, 2020
    Publication date: July 16, 2020
    Inventors: Dov Tamarkin, David Schuz, Tal Berman, Yohan Hazot
  • Topical tetracycline compositions
    Patent number: 10610599
    Abstract: A topical therapeutic hydrophobic breakable composition includes a carrier comprising (a) about 60% to about 99% by weight of at least one hydrophobic oil; (b) at least one viscosity-modifying agents selected from the group consisting of a fatty alcohol, a fatty acid and a wax; and (c) a tetracycline antibiotic, characterized in that at least part of the tetracycline antibiotic is suspended in the composition; the viscosity of the composition is at least about 30% higher than the viscosity of the carrier without the tetracycline antibiotic; and is higher than the viscosity of the hydrophobic oil and the tetracycline antibiotic without the viscosity modifying agents. The tetracycline is chemically stable in the composition for at least six months; wherein more than about 90% of the tetracycline has not broken down. The composition is packaged as a breakable foam that breaks easily upon application of shear force.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: April 7, 2020
    Assignee: Foamix Pharmaceuticals Ltd.
    Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan